Munteanu, R.A., Moldovan, C.S., Tigu, A.B., Drula, R., Feder, R., Magdo, L., Jurj, A., Raduly, L., Budisan, L., Pirlog, R., Moldovan, A., Zimta, A.A., Braicu, C., Preda, A., Munteanu, V., Romitan, M., Gulei, D. and Ciuleanu, T.E. 2024. 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Medicine and Pharmacy Reports. 97, 4 (Sep. 2024), 488–506. DOI:https://doi.org/10.15386/mpr-2777.